Baidu
map

湖南桃江县肺结核疫情:50名学生已达复学标准

2017-11-20 付敬懿 中国新闻网

桃江县政府还在新闻发布会现场承诺,及时准确发布疫情信息,并严肃查处此次结核病聚集性疫情处置工作中失职渎职行为。

湖南省益阳市桃江县人民政府19日晚召开新闻发布会称,截至11月16日,此次桃江县第四中学肺结核聚集性疫情中共计有72名学生接受治疗和管理,其中已有50名学生达到复学标准,其余22名学生定期复查,一旦达到相关标准即可复学。

2017年8月,桃江县第四中学发生结核病聚集性疫情。经湖南省卫生和计划生育委员会确认:截至2017年11月16日,共发现肺结核确诊病例29例(已治愈3例)、疑似病例5例,另有38名学生预防性服药,其中9例在外地接受治疗。

桃江县人民政府在发布会上称,8月19日疫情发生当晚,县委、县政府组织召开紧急会议,成立应急处置指挥部,启动突发公共卫生事件Ⅳ级应急响应,制定了应急响应实施方案,研究制定并落实了患病学生治疗、学习、生活等方面的处置措施。

11月13日,再次发现6起确诊和疑似病例。11月14日至19日,县委、县政府连续组织召开紧急会议,完善研究部署治疗服务、学习帮扶、疫情防控等工作。从11月16日开始,连续在桃江公众信息网发布疫情处置信息。

而患病学生所有门诊、住院治疗费用按医保政策报销后,剩余部分由县政府统筹解决,已报销第一批22名患病学生医疗费17万多元;对服药治疗6个月、9个月的患病学生分别救助3000元、5000元,免除今年复学学生的学费和校内住宿费,在校就餐的在治学生每人每月补助生活费300元;免除今年因病休学、明年继续在桃江四中学习的学生学费;对到上级指定医院就诊的,报销诊断费用。

下一步,桃江县将申请省、市专家援助全面会诊,与湖南省胸科医院会商,开辟“绿色通道”。同时桃江四中教室、食堂、宿舍等场所也将继续进行清洁、消毒和通风,政府部门还将加强桃江四中密切接触人群筛查,以及其它寄宿制学校、中小学校日常监测。

针对部分家长反映质疑的县疾控中心的数字与家长的统计存在出入、桃江县隐瞒疫情等情况,桃江县人民政府表示,当地严格按照国家传染病报告与《传染病防治法》要求,24小时内上报疫情到专报网,不会出现漏报与迟报,不存在隐瞒疫情。

桃江县政府还在新闻发布会现场承诺,将及时解决患病学生家长提出的合理诉求,及时准确发布疫情信息,并严格依规依纪,严肃查处此次结核病聚集性疫情处置工作中失职渎职行为。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1254111, encodeId=fbe41254111eb, content=<a href='/topic/show?id=f30ae86297d' target=_blank style='color:#2F92EE;'>#结核#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78629, encryptionId=f30ae86297d, topicName=结核)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=huhuaidong387, createdTime=Wed Nov 22 00:00:00 CST 2017, time=2017-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=262882, encodeId=abe026288276, content=保官帽为主的时代.其实人没那么重要, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201208/af76c3dece7248f2b297751d57470291/d45c15338e034c3f847da0bca70bfa4d.jpg, createdBy=3cfe1656094, createdName=cscs, createdTime=Mon Nov 20 18:02:55 CST 2017, time=2017-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=262874, encodeId=33692628e43a, content=了解了解.继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Mon Nov 20 17:06:14 CST 2017, time=2017-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=262795, encodeId=c7c4262e9543, content=学习了谢谢了, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLPeNmuNF9ibgMfMOAs7Iic5MpiaU8RLmRH67xCKuk5wzfhb7G4ib7ia6z9lrnsTicj1nAUfEOMecZDtvvu/0, createdBy=d7f91939785, createdName=186****0580(小山羊), createdTime=Mon Nov 20 09:46:12 CST 2017, time=2017-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=262783, encodeId=5008262e8358, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3da1990174, createdName=yfjms, createdTime=Mon Nov 20 09:12:54 CST 2017, time=2017-11-20, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1254111, encodeId=fbe41254111eb, content=<a href='/topic/show?id=f30ae86297d' target=_blank style='color:#2F92EE;'>#结核#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78629, encryptionId=f30ae86297d, topicName=结核)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=huhuaidong387, createdTime=Wed Nov 22 00:00:00 CST 2017, time=2017-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=262882, encodeId=abe026288276, content=保官帽为主的时代.其实人没那么重要, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201208/af76c3dece7248f2b297751d57470291/d45c15338e034c3f847da0bca70bfa4d.jpg, createdBy=3cfe1656094, createdName=cscs, createdTime=Mon Nov 20 18:02:55 CST 2017, time=2017-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=262874, encodeId=33692628e43a, content=了解了解.继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Mon Nov 20 17:06:14 CST 2017, time=2017-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=262795, encodeId=c7c4262e9543, content=学习了谢谢了, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLPeNmuNF9ibgMfMOAs7Iic5MpiaU8RLmRH67xCKuk5wzfhb7G4ib7ia6z9lrnsTicj1nAUfEOMecZDtvvu/0, createdBy=d7f91939785, createdName=186****0580(小山羊), createdTime=Mon Nov 20 09:46:12 CST 2017, time=2017-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=262783, encodeId=5008262e8358, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3da1990174, createdName=yfjms, createdTime=Mon Nov 20 09:12:54 CST 2017, time=2017-11-20, status=1, ipAttribution=)]
    2017-11-20 cscs

    保官帽为主的时代.其实人没那么重要

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1254111, encodeId=fbe41254111eb, content=<a href='/topic/show?id=f30ae86297d' target=_blank style='color:#2F92EE;'>#结核#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78629, encryptionId=f30ae86297d, topicName=结核)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=huhuaidong387, createdTime=Wed Nov 22 00:00:00 CST 2017, time=2017-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=262882, encodeId=abe026288276, content=保官帽为主的时代.其实人没那么重要, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201208/af76c3dece7248f2b297751d57470291/d45c15338e034c3f847da0bca70bfa4d.jpg, createdBy=3cfe1656094, createdName=cscs, createdTime=Mon Nov 20 18:02:55 CST 2017, time=2017-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=262874, encodeId=33692628e43a, content=了解了解.继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Mon Nov 20 17:06:14 CST 2017, time=2017-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=262795, encodeId=c7c4262e9543, content=学习了谢谢了, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLPeNmuNF9ibgMfMOAs7Iic5MpiaU8RLmRH67xCKuk5wzfhb7G4ib7ia6z9lrnsTicj1nAUfEOMecZDtvvu/0, createdBy=d7f91939785, createdName=186****0580(小山羊), createdTime=Mon Nov 20 09:46:12 CST 2017, time=2017-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=262783, encodeId=5008262e8358, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3da1990174, createdName=yfjms, createdTime=Mon Nov 20 09:12:54 CST 2017, time=2017-11-20, status=1, ipAttribution=)]
    2017-11-20 1dd8c52fm63(暂无匿称)

    了解了解.继续关注

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1254111, encodeId=fbe41254111eb, content=<a href='/topic/show?id=f30ae86297d' target=_blank style='color:#2F92EE;'>#结核#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78629, encryptionId=f30ae86297d, topicName=结核)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=huhuaidong387, createdTime=Wed Nov 22 00:00:00 CST 2017, time=2017-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=262882, encodeId=abe026288276, content=保官帽为主的时代.其实人没那么重要, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201208/af76c3dece7248f2b297751d57470291/d45c15338e034c3f847da0bca70bfa4d.jpg, createdBy=3cfe1656094, createdName=cscs, createdTime=Mon Nov 20 18:02:55 CST 2017, time=2017-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=262874, encodeId=33692628e43a, content=了解了解.继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Mon Nov 20 17:06:14 CST 2017, time=2017-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=262795, encodeId=c7c4262e9543, content=学习了谢谢了, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLPeNmuNF9ibgMfMOAs7Iic5MpiaU8RLmRH67xCKuk5wzfhb7G4ib7ia6z9lrnsTicj1nAUfEOMecZDtvvu/0, createdBy=d7f91939785, createdName=186****0580(小山羊), createdTime=Mon Nov 20 09:46:12 CST 2017, time=2017-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=262783, encodeId=5008262e8358, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3da1990174, createdName=yfjms, createdTime=Mon Nov 20 09:12:54 CST 2017, time=2017-11-20, status=1, ipAttribution=)]
    2017-11-20 186****0580(小山羊)

    学习了谢谢了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1254111, encodeId=fbe41254111eb, content=<a href='/topic/show?id=f30ae86297d' target=_blank style='color:#2F92EE;'>#结核#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78629, encryptionId=f30ae86297d, topicName=结核)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=huhuaidong387, createdTime=Wed Nov 22 00:00:00 CST 2017, time=2017-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=262882, encodeId=abe026288276, content=保官帽为主的时代.其实人没那么重要, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201208/af76c3dece7248f2b297751d57470291/d45c15338e034c3f847da0bca70bfa4d.jpg, createdBy=3cfe1656094, createdName=cscs, createdTime=Mon Nov 20 18:02:55 CST 2017, time=2017-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=262874, encodeId=33692628e43a, content=了解了解.继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Mon Nov 20 17:06:14 CST 2017, time=2017-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=262795, encodeId=c7c4262e9543, content=学习了谢谢了, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLPeNmuNF9ibgMfMOAs7Iic5MpiaU8RLmRH67xCKuk5wzfhb7G4ib7ia6z9lrnsTicj1nAUfEOMecZDtvvu/0, createdBy=d7f91939785, createdName=186****0580(小山羊), createdTime=Mon Nov 20 09:46:12 CST 2017, time=2017-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=262783, encodeId=5008262e8358, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3da1990174, createdName=yfjms, createdTime=Mon Nov 20 09:12:54 CST 2017, time=2017-11-20, status=1, ipAttribution=)]
    2017-11-20 yfjms

    学习

    0

相关资讯

Chest:What?他汀还能降低肺结核风险

有研究表明,他汀类药物可能会降低感染疾病和感染相关死亡率的风险。2017年9月,发表在《Chest》的一项基于人群的研究调查了他汀与活动性肺结核(TB)之间的相关性。结果表明,他汀与较低的TB风险相关。

Nat Commun:科学家锁定肺结核的“罪魁祸首”,有望彻底“消灭”肺结核

科学家们解决了十年之久的谜团,这将带来肺结核的治疗方法,据统计,肺结核是全世界最致命的疾病之一,影响着全球20亿人口。

湖南桃江通报中学肺结核突发事件:近九成学生已复学或可复学

2017年8月19日,桃江县第四中学发生肺结核病突发公共卫生应急事件。疫情发生后,县委、县政府高度重视,第一时间启动县级突发公共卫生事件应急预案,并报告省、市疾控中心,立即开展治疗防控工作。

MCP:肺结核治疗潜在的药物靶点

肺结核是全球致死率最高的几种感染性疾病之一,每年有将近150万人死于肺结核感染。肺结核的主要致病菌是肺结核分枝杆菌(Mycobacterium tuberculosis, Mtb)。由于与HIV的共感染以及结核菌耐药问题的日益严重,结核病仍然是全球公共卫生领域的重大威胁。近日,国际杂志MCP在线发表了一遍关于肺结核治疗新靶点的研究。

世界防治结核病日 盘点近年来结核病研究领域的亮点成果

今年3月24日是第22个世界防治结核病日,今年的结核病日的宣传主题是“社会共同努力,消除结核危害”。2016年,世卫组织报告全球1040万人患结核病,2015年有180万因结核病死亡,如今结核病已经成为世界上最大的传染病杀手,这种疾病深深植根于人权和尊严受限的人群中。 近些年来,科学家们在结核病研究领域取得了很多突破性的进展,本文中小编就对此进行了整理,与各位一起共同学习!

Lancet Infect Dis:耐药性肺结核的流行趋势

印度、菲律宾、俄罗斯和南非4个国家的多药耐药以及扩大耐药型肺结核比例将达到较高水平,加强药物抵抗预防将有助于减缓耐药性肺结核在全球的流行趋势

Baidu
map
Baidu
map
Baidu
map